A team of Inserm researchers from the Cardio-Thoracic Research Centre of Bordeaux (Inserm/University of Bordeaux and Bordeaux University Hospital) has demonstrated the clinical efficacy of gallopamil in 31 patients with severe asthma. This chronic disease is characterized by remodeling of the bronchi, which exacerbates the obstruction of the airways already seen in ‘classic’ asthma. In contrast to the reference treatment, gallopamil has proved capable of reducing the bronchial smooth muscle mass. … – Source
Severe asthma: Gallopamil confirmed as a therapeutic approach
No comments:
Post a Comment